{"id":107249,"date":"2023-08-17T12:18:11","date_gmt":"2023-08-17T06:48:11","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=107249"},"modified":"2023-08-17T12:18:12","modified_gmt":"2023-08-17T06:48:12","slug":"glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/","title":{"rendered":"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03%"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1124612747\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. <\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-2149330482\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>The company has 10 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries.\u00a0<\/p><p>In Vivo\/Scrip 100 positions Glenmark amongst the Top 100 Companies Ranked by R&amp;D and Pharmaceutical Sales, 2021; while Generics Bulletin\/In Vivo places it in the Top 50 Generics and Biosimilars Companies Ranked by Sales, 2021. The organization has impacted over 2.9 million lives over the last decade through its CSR interventions<\/p><p><strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/GLENMARK\/consolidated\">Glenmark Pharmaceuticals Ltd.<\/a><\/strong> (Glenmark), a research-led, integrated, global pharmaceutical company has received the final approval from the United States Food &amp; Drug Administration (U.S. FDA) for Tacrolimus Ointment, 0.03%, the generic version of Protopic1 Ointment, 0.03%, of Leo Pharma AS. Glenmark&#8217;s Tacrolimus Ointment, 0.03%, will be distributed in the U.S. by Glenmark Pharmaceuticals Inc., USA.<\/p><div class=\"trade-content_5\" id=\"trade-2567101553\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>According to IQVIATM sales data for the 12-month period ending June 2023, the Protopic Ointment, 0.03% market2 achieved annual sales of approximately $15.4 million*.<\/p><p>Glenmark&#8217;s current portfolio consists of 184 products authorised for distribution in the U.S. marketplace and 51 ANDAs pending approval with the U.S. FDA. In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.<\/p><div class=\"trade-after-content\" id=\"trade-3951231390\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries.\u00a0 In Vivo\/Scrip 100 positions Glenmark amongst the Top [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":106029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[1696,31],"tags":[],"class_list":["post-107249","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-corporate-action","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03% - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03%\" \/>\n<meta property=\"og:description\" content=\"Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-17T06:48:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-17T06:48:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/\",\"url\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/\",\"name\":\"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03% - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\",\"datePublished\":\"2023-08-17T06:48:11+00:00\",\"dateModified\":\"2023-08-17T06:48:12+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg\",\"width\":1280,\"height\":854},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03%\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03% - Trade Brains Features","description":"Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/","og_locale":"en_US","og_type":"article","og_title":"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03%","og_description":"Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.","og_url":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-08-17T06:48:11+00:00","article_modified_time":"2023-08-17T06:48:12+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/","url":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/","name":"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03% - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","datePublished":"2023-08-17T06:48:11+00:00","dateModified":"2023-08-17T06:48:12+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Glenmark Pharmaceuticals Ltd. is an integrated, research\u2013led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology.","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/08\/glenmark.jpg","width":1280,"height":854},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/glenmark-pharmaceuticals-has-received-anda-approval-for-tacrolimus-ointment-0-03\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Glenmark Pharmaceuticals has received ANDA approval for Tacrolimus Ointment, 0.03%"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107249","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=107249"}],"version-history":[{"count":3,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107249\/revisions"}],"predecessor-version":[{"id":107254,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/107249\/revisions\/107254"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/106029"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=107249"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=107249"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=107249"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}